Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma

We have previously reported that Cezanne could be a prognostic biomarker for survival in hepatocellular carcinoma (HCC) patients. However, the role of Cezanne genes in HCC cells and its response to postoperative adjuvant transcatheter arterial chemoembolization (TACE) in HCC patients remains unknown...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cell Death Dis
Hoofdauteurs: Wang, Jia-hong, Zhong, Xiao-ping, Zhang, Yong-fa, Wu, Xiao-liang, Li, Shao-hua, Jian, Pei-en, Ling, Yi-hong, Shi, Ming, Chen, Min-shan, Wei, Wei, Guo, Rong-ping
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2017
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5636974/
https://ncbi.nlm.nih.gov/pubmed/28880268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.428
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items